Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780660-25-000002

Chief People Officer sold 113,890 shares at $15.57 ($1,773,267)

  • Chief People Officer acquired 97,022 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LO FRANCIS · Chief People Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-15 Exercise or conversion : show line 1 in the form 10b5-1 +37,750 $7.80 $294,450 370,596 D
2025-12-15 Exercise or conversion : show line 2 in the form 10b5-1 +19,423 $8.46 $164,319 390,019 D
2025-12-15 Exercise or conversion : show line 3 in the form 10b5-1 +39,849 $3.99 $158,998 429,868 D
2025-12-15 Sale : show line 4 in the form 10b5-1 −113,890 $15.57 $1,773,267 315,978 D
Open-market sales · 113,890 sh · avg $15.57 · $1,773,267

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-12-15 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −37,750 113,250 D
2025-12-15 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −19,423 109,176 D
2025-12-15 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −39,849 110,175 D
Loading xslF345X05/primary_doc.xml…